Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Regulatory changes may influence farm costs and operations.
Lower hop stocks may support prices in the near term.
Biofuel policy decisions may influence planting economics. Today, March 18, is also National Biodiesel Day.
APHIS Veterinary Medical Officer Dr. Chelsey Shiveley discusses USDA’s biosecurity resources available to poultry producers ahead of spring migration, increasing the risk of Highly Pathogenic Avian Influenza (HPAI) threatens commercial flocks.
This year at CattleCon 2026, RFD Network’s Kirbe Schnoor caught up with Donna Emick from Pneu-Dart to get her perspective on why education, safety, and accountability matter in the field.
Nebraska’s largest wildfire on-record has burned 650,000 acres, with three other major fires also burning across the state, destroying pastureland and threatening cattle.
